med-mastodon.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Medical community on Mastodon

Administered by:

Server stats:

389
active users

David Gregory

New study! Learning about inflammation by studying the differences between mammals – a toot-orial.

doi.org/10.1186/s10020-024-010

When the body meets an infectious microbe or similar challenge it activates an inflammatory cascade. Inflammation helps eliminate the microbe, but, if it gets of control, it can be dangerous or even fatal.

We like to assume that inflammation is basically the same for all animals. And this is usually true in cell culture, but in vivo …

1/

BioMed CentralMolecular profiles of blood from numerous species that differ in sensitivity to acute inflammation - Molecular MedicineVertebrates differ over 100,000-fold in responses to pro-inflammatory agonists such as bacterial lipopolysaccharide (LPS), complicating use of animal models to study human sepsis or inflammatory disorders. We compared transcriptomes of resting and LPS-exposed blood from six LPS-sensitive species (rabbit, pig, sheep, cow, chimpanzee, human) and four LPS-resilient species (mice, rats, baboon, rhesus), as well as plasma proteomes and lipidomes. Unexpectedly, at baseline, sensitive species already had enhanced expression of LPS-responsive genes relative to resilient species. After LPS stimulation, maximally different genes in resilient species included genes that detoxify LPS, diminish bacterial growth, discriminate sepsis from SIRS, and play roles in autophagy and apoptosis. The findings reveal the molecular landscape of species differences in inflammation. This may inform better selection of species for pre-clinical models and could lead to new therapeutic strategies that mimic mechanisms in inflammation-resilient species to limit inflammation without causing immunosuppression.

“Mice lie and monkeys don’t always tell the truth.”

Mice can survive injection with hundreds- or thousands-fold more bacterial product than would kill a human. Some monkeys are also very resilient but rabbits and sheep are sensitive, like humans.

This is a problem. Are all the studies where people have injected LPS into mice and monkeys to study inflammation irrelevant?

2/

But, wait – mice have healthy and robust immune systems. They can resist bacterial and viral infections at least as well as humans, and aren’t especially prone to cancer. So how do they do that without risking the runaway, systemic inflammation that can kill a human?

Might it possible to treat patients so that they don’t suffer excessive inflammation while still fighting off infections?

We set out to find out what causes the difference.

3/

We took blood from 10 different species of mammal with very different susceptibility to lethal inflammation, and measured the gene expression in the white blood cells as well as lipids and proteins in the plasma. We measured both naïve blood and blood after ex vivo stimulation with LPS.

We used the same reagents and protocol for all our species to control against batch effects and experimental factors that plague attempts to compare comparison of omic datasets.

4/

We didn’t find many differences in the lipidome or proteomes that correlated with sensitivity to inflammation. But in the transcriptomes ….

Leukocytes from resilient and sensitive species respond differently to LPS, including by genes involved in LPS detoxification and metabolism.

Most surprisingly, even without stimulation, we could distinguish sensitive species from resilient ones.

5/

Compared to resilient cells, the transcriptomes of sensitive cells showed a more inflammatory phenotype, as though they had already been stimulated with LPS. The biggest differences tended to be in genes that aren’t themselves LPS responsive but encode proteins that mediate inflammatory signalling, such as Myd88 and other members of the cascade.

6/

It will be important to understand how these differences in gene expression contribute to regulation of inflammation and susceptibility to systemic inflammation. Interventions that modulate inflammation to produce a “mouse-like” phenotype could be a powerful new therapeutic strategy for acute inflammatory diseases like , , or .

doi.org/10.1186/s10020-024-010

/end

BioMed CentralMolecular profiles of blood from numerous species that differ in sensitivity to acute inflammation - Molecular MedicineVertebrates differ over 100,000-fold in responses to pro-inflammatory agonists such as bacterial lipopolysaccharide (LPS), complicating use of animal models to study human sepsis or inflammatory disorders. We compared transcriptomes of resting and LPS-exposed blood from six LPS-sensitive species (rabbit, pig, sheep, cow, chimpanzee, human) and four LPS-resilient species (mice, rats, baboon, rhesus), as well as plasma proteomes and lipidomes. Unexpectedly, at baseline, sensitive species already had enhanced expression of LPS-responsive genes relative to resilient species. After LPS stimulation, maximally different genes in resilient species included genes that detoxify LPS, diminish bacterial growth, discriminate sepsis from SIRS, and play roles in autophagy and apoptosis. The findings reveal the molecular landscape of species differences in inflammation. This may inform better selection of species for pre-clinical models and could lead to new therapeutic strategies that mimic mechanisms in inflammation-resilient species to limit inflammation without causing immunosuppression.